J GUADALUPE GALLO PADILLA: Open Payments
NPI 1447680947 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,205 in 66 payments from 14 companies in 2025. Trend: 2023 $968 · 2024 $827 · 2025 $1,205
Food & beverage: $1,205
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $341 |
| AstraZeneca Pharmaceuticals LP | 11 | $221 |
| Novo Nordisk Inc | 6 | $117 |
| Saluda Medical Americas, Inc. | 3 | $112 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $97 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $75 |
| Lilly USA, LLC | 4 | $67 |
| Abbott Laboratories | 2 | $51 |
| Astellas Pharma US Inc | 1 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
Products named: QULIPTA, AIRSUPRA, Evoke, Kerendia, UBRELVY, Ozempic, XIFAXAN, MOUNJARO.
Industry payments across AZ — which companies pay providers there.
